| Suzanne Probst Prinz, | |
|
509 Biltmore Ave, Asheville, NC 28801-4601 | |
| (828) 213-1111 | |
| Not Available |
| Full Name | Suzanne Probst Prinz |
|---|---|
| Gender | Female |
| Speciality | Registered Nurse - Registered Nurse First Assistant |
| Location | 509 Biltmore Ave, Asheville, North Carolina |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1508512021 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163WR0006X | Registered Nurse - Registered Nurse First Assistant | C11090 (North Carolina) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Suzanne Probst Prinz, 509 Biltmore Ave, Asheville, NC 28801-4601 Ph: (828) 213-1111 | Suzanne Probst Prinz, 509 Biltmore Ave, Asheville, NC 28801-4601 Ph: (828) 213-1111 |
News Archive
Researchers recently conducted a systematic review on the impact of eye protection on the transmission of SARS-CoV-2.
EKR Therapeutics, Inc., a specialty pharmaceutical company focused on commercializing acute-care hospital products, today announced that the US Patent and Trademark Office has issued two new patents covering methods of treatment and methods of preparation for the Company's Ready-to-Use (RTU) Cardene® I.V. (nicardipine hydrochloride) Premixed Injection.
A health insurer ends two Medicare Advantage programs in Connecticut, while providers nationwide examine a Medicare demonstration program in Texas.
The Johns Hopkins School of Medicine, the nation's leading medical school recipient of research funds from the National Institutes of Health and a recognized center for "Best Practices" by the Accreditation Council for Continuing Medical Education, discussed the development of a unique medical education initiative - the Rheumatoid Arthritis Action Lab Initiative - to give healthcare providers connectivity to much-needed information on rheumatoid arthritis.
Peregrine Pharmaceuticals, Inc. today announced that the U.S. Patent and Trademark Office has issued U.S. Patent Number 7,611,704, which includes broad claims covering anti-viral uses of phosphatidylserine (PS)-targeting antibodies including Peregrine's lead clinical compound, bavituximab. PS is a unique marker exposed on the surface of virally infected cells that can be targeted to treat a broad spectrum of virus infections.
› Verified 9 days ago
Judith Carol Wrzesinski, CNM Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 24 Snelson Dr, Asheville, NC 28806 Phone: 828-515-5227 Fax: 828-515-5227 | |
Blair Ashley Powers, CRNA Registered Nurse Medicare: Medicare Enrolled Practice Location: 76 Peachtree Rd Ste 300, Asheville, NC 28803 Phone: 828-274-3477 Fax: 828-274-7407 | |
Mr. Brian Michael Fortune, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 509 Biltmore Ave, Asheville, NC 28801 Phone: 828-213-1111 | |
Dawn C Lamb, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 35 Woodfin St, Asheville, NC 28801 Phone: 828-250-5000 Fax: 828-250-6095 | |
Antoinette Marie Ancarana, CRNA Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 76 Peachtree Rd, Suite 300, Asheville, NC 28803 Phone: 828-274-3477 Fax: 828-274-7407 | |
Sheila Ann Thibodeaux, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 277 Biltmore Ave, Asheville, NC 28801 Phone: 877-277-8873 Fax: 828-505-0366 | |
Ms. Julia Taylor Gaines, R.N., BC Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 35 Woodfin St, Asheville, NC 28801 Phone: 828-250-5064 Fax: 828-250-6095 |